Targeting factor XI: innovations in anticoagulation

29 August 2025 (07:00 - 18:00)

Organised by:

Sign in to view the resources

Sign in to view the resources

About the speaker

Doctor Jeffrey Weitz

Thrombosis & Atherosclerosis Research Institute (TaARI), Hamilton (Canada)

5 More presentations in this session

Presentation thumbnail

Welcome

Professor C. Lam (Singapore, SG)

Presentation thumbnail

Stroke prevention in atrial fibrillation and MACE after acute coronary syndrome: prevalence and challenges

Professor D. Capodanno (Catania, IT)

Presentation thumbnail

Current treatments in atrial fibrillation and acute coronary syndrome, safety and guidelines

Doctor S. Jain (Palo Alto, US)

Presentation thumbnail

Shaping clinical practice and clinical trials

Professor C. Lam (Singapore, SG)

Presentation thumbnail

Audience Q&A and closing remarks

Professor C. Lam (Singapore, SG) Doctor S. Jain (Palo Alto, US) Professor D. Capodanno (Catania, IT) Doctor J. Weitz (Hamilton, CA)

Access the full session

Session thumbnail

Revolutionising thrombosis treatment in acute coronary syndrome (ACS), secondary stroke prevention (SSP) and atrial fibrillation (AF): bridging the gaps with next generation anticoagulation strategies

The Event

Event poster

ESC Congress 2025

29 August - 1 September 2025

You may be interested in

Congress Presentation

Factor XI inhibition uncoupled: mechanistic insights and rationale

Congress Session

Advances in thrombosis management: evaluating current and emerging anticoagulation strategies

Congress Session

Revolutionising thrombosis treatment in acute coronary syndrome (ACS), secondary stroke prevention (SSP) and atrial fibrillation (AF): bridging the gaps with next generation anticoagulation strategies

ESC 365 is supported by

novartis

Explore sponsored resources

ESC 365 is supported by

novartis

Explore sponsored resources